Vimal Mehta
2019
In 2019, Vimal Mehta earned a total compensation of $2M as President and Chief Executive Officer at BioXcel Therapeutics, a 181% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $233,000 |
|---|---|
| Option Awards | $1,269,131 |
| Salary | $459,000 |
| Other | $7,800 |
| Total | $1,968,931 |
Mehta received $1.3M in option awards, accounting for 64% of the total pay in 2019.
Mehta also received $233K in non-equity incentive plan, $459K in salary and $7.8K in other compensation.
Rankings
In 2019, Vimal Mehta's compensation ranked 6,005th out of 13,971 executives tracked by ExecPay. In other words, Mehta earned more than 57.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,005 out of 13,971 | 57th |
Division Manufacturing | 2,250 out of 5,701 | 61st |
Major group Chemicals And Allied Products | 812 out of 2,200 | 63rd |
Industry group Drugs | 685 out of 1,886 | 64th |
Industry Pharmaceutical Preparations | 506 out of 1,398 | 64th |
Source: SEC filing on April 6, 2020.
Mehta's colleagues
We found two more compensation records of executives who worked with Vimal Mehta at BioXcel Therapeutics in 2019.
News
BioXcel Therapeutics CEO Vimal Mehta's 2023 pay rises 4% to $4.7M
April 29, 2024
BioXcel Therapeutics CEO Vimal Mehta's 2022 pay falls 51% to $4.6M
May 17, 2023
BioXcel Therapeutics CEO Vimal Mehta's 2021 pay slips 2% to $9.4M
April 5, 2022
BioXcel Therapeutics CEO Vimal Mehta's 2020 pay jumps 386% to $9.6M
April 27, 2021
BioXcel Therapeutics CEO Vimal Mehta's 2019 pay jumps 181% to $2M
April 6, 2020
BioXcel Therapeutics CEO Vimal Mehta's 2018 pay jumps 147% to $702K
April 1, 2019